{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:29:43Z","timestamp":1790526583450,"version":"4.1.0"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Autism spectrum disorders (ASD) is a complex neurodevelopmental disorder that lacks an ideal animal model to recapitulate the disease state of ASD. Previous studies have reported that transplanting gut microbiota of ASD patients into pregnant mice is sufficient to promote the changes of autism-like behavior in offspring. This study aims to explore whether fecal microbiota transplantation (FMT) can be used as a new method to establish the ASD animal model.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We transplanted the fecal sample extract of ASD children into pregnant rats (rFMT) repeatedly to establish an ASD rat model (oFMT) and compare it with the classical valproic acid (VPA) model (oVPA).<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> First, we reveal that oFMT shows hypoevolutism and typical behavioral characteristics of ASD, consistent with the previous study. Second, the gut microbiota of oFMT mainly consists of <jats:italic>Firmicutes<\/jats:italic> and <jats:italic>Bacteroidetes<\/jats:italic>, recapitulating the abnormal gut microbiota of ASD. In oFMT, the abundance of <jats:italic>Lactobacillus<\/jats:italic> and <jats:italic>Collinsella<\/jats:italic> increased (<jats:italic>Lactobacillus: oFMT 60.16%, oVPA 64.13%, oCON 40.11%; Collinsella: oFMT 3.73%, oVPA 1.39%, oCON 1.28%<\/jats:italic>), compared with oVPA, gut microbiota also showed high consistency. Third, the expression of 5-hydroxytryptamine (5-HT) in oFMT serum increased, \u03b3-aminobutyric acid (GABA) and norepinephrine (NE) in oFMT serum decreased. Fourth, the gut microbiota of oFMT also has some ASD characteristic gut microbiota not found in oVPA. Fifth, pregnant rat with VPA showed significant immune activation, while those with FMT showed relatively minor immune activation.<\/jats:p><jats:p><jats:bold>Limitations:<\/jats:bold> Although the mechanism of establishing FMT autism rat model (oFMT) has not clearly defined, the data show that the model has high structural validity, and FMT model is likely to be a new and reliable potential animal model of ASD, and will have potential value in studying gut microbiota of ASD.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> The FMT autism rat model has high structural validity, and the FMT model is likely to be a new and reliable potential animal model of ASD.<\/jats:p>","DOI":"10.3389\/fpsyt.2021.549810","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T05:15:30Z","timestamp":1615526130000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["A Novel and Reliable Rat Model of Autism"],"prefix":"10.3389","volume":"12","author":[{"given":"Zhaoyao","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengke","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","article-title":"The valproic acid-induced rodent model of autism","volume":"299","author":"Nicolini","year":"2018","journal-title":"Exp Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/j.cell.2019.05.004","article-title":"Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice","volume":"177","author":"Sharon","year":"2019","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.cell.2013.11.024","article-title":"Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders","volume":"155","author":"Hsiao","year":"2013","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.cell.2013.11.035","article-title":"Toward effective probiotics for autism and other neurodevelopmental disorders","volume":"155","author":"Gilbert","year":"2013","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e76993","DOI":"10.1371\/journal.pone.0076993","article-title":"Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified","volume":"8","author":"De Angelis","year":"2013","journal-title":"PloS ONE"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s10803-013-1973-x","article-title":"Gastrointestinal problems in children with autism, developmental delays or typical development","volume":"44","author":"Chaidez","year":"2014","journal-title":"J Autism Dev Disor"},{"key":"B7","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.cell.2016.10.027","article-title":"The central nervous system and the gut microbiome","volume":"167","author":"Sharon","year":"2016","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"26309","DOI":"10.3402\/mehd.v26.26309","article-title":"The human gut microbiota with reference to autism spectrum disorder: considering the whole as more than a sum of its parts","volume":"26","author":"Toh","year":"2015","journal-title":"Microbial Ecol Health Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.3389\/fmicb.2018.03146","article-title":"Gut microbiota features in young children with autism spectrum disorders","volume":"9","author":"Coretti","year":"2018","journal-title":"Front Microbiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.anaerobe.2017.12.007","article-title":"Differences in fecal microbial metabolites and microbiota of children with autism spectrum disorders","volume":"49","author":"Kang","year":"2018","journal-title":"Anaerobe"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e00321","DOI":"10.1128\/mSystems.00321-18","article-title":"Alterations in gut glutamate metabolism associated with changes in gut microbiota composition in children with autism spectrum disorder","volume":"4","author":"Wang","year":"2019","journal-title":"mSystems"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.cgh.2011.08.014","article-title":"Treating Clostridium difficile infection with fecal microbiota transplantation","volume":"9","author":"Bakken","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"van Nood","year":"2013","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"G310","DOI":"10.1152\/ajpgi.00282.2013","article-title":"Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection","volume":"306","author":"Weingarden","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"bcr2016217209","DOI":"10.1136\/bcr-2016-217209","article-title":"Faecal microbiota transplantation for recurring Clostridium difficile infection in a patient with Crohn's disease and ileorectal anastomosis","volume":"2016","author":"Oppfeldt","year":"2016","journal-title":"BMJ Case Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.3748\/wjg.v23.i19.3565","article-title":"Fecal microbiota transplantation cured epilepsy in a case with Crohn's disease: The first report","volume":"23","author":"He","year":"2017","journal-title":"World J Gastroenterol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40168-016-0225-7","article-title":"Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study","volume":"5","author":"Kang","year":"2017","journal-title":"Microbiome"},{"key":"B18","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1038\/s41598-019-42183-0","article-title":"Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota","volume":"9","author":"Kang","year":"2019","journal-title":"Scientific Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.gie.2013.03.1329","article-title":"An overview of fecal microbiota transplantation: techniques, indications, and outcomes","volume":"78","author":"Brandt","year":"2013","journal-title":"Gastrointest Endos"},{"key":"B20","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/apt.13868","article-title":"Consensus report: faecal microbiota transfer - clinical applications and procedures","volume":"45","author":"Konig","year":"2017","journal-title":"Aliment Pharmacol Therapeut"},{"key":"B21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1126\/science.aat7164","article-title":"Transmission modes of the mammalian gut microbiota","volume":"362","author":"Moeller","year":"2018","journal-title":"Science (New York, NY)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ijdevneu.2007.08.017","article-title":"The effects of maternal inflammation on neuronal development: possible mechanisms","volume":"25","author":"Jonakait","year":"2007","journal-title":"Int J Deve Neurosci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1189\/jlb.1205707","article-title":"The immune response in autism: a new frontier for autism research","volume":"80","author":"Ashwood","year":"2006","journal-title":"J Leukoc Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.neubiorev.2004.10.012","article-title":"Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia","volume":"29","author":"Meyer","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nature23910","article-title":"Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring","volume":"549","author":"Kim","year":"2017","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/mrdd.20039","article-title":"Designing mouse behavioral tasks relevant to autistic-like behaviors","volume":"10","author":"Crawley","year":"2004","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/sj.npp.1300518","article-title":"Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism","volume":"30","author":"Schneider","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1017\/S1461145711001714","article-title":"Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid","volume":"16","author":"Kataoka","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e26077","DOI":"10.1371\/journal.pone.0026077","article-title":"mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism","volume":"6","author":"Mehta","year":"2011","journal-title":"PloS ONE"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e104927","DOI":"10.1371\/journal.pone.0104927","article-title":"Subchronic treatment of donepezil rescues impaired social, hyperactive, and stereotypic behavior in valproic acid-induced animal model of autism","volume":"9","author":"Kim","year":"2014","journal-title":"PloS ONE"},{"key":"B31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/mrdd.20134","article-title":"Early communication development and intervention for children with autism","volume":"13","author":"Landa","year":"2007","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijdevneu.2004.05.001","article-title":"Behavioral manifestations of autism in the first year of life","volume":"23","author":"Zwaigenbaum","year":"2005","journal-title":"Int J Dev Neurosci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1126\/science.341.6149.954","article-title":"Medical research. The promise of poop","volume":"341","author":"de Vrieze","year":"2013","journal-title":"Science (New York, NY)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.molmed.2014.05.002","article-title":"Microbiota and neurodevelopmental windows: implications for brain disorders","volume":"20","author":"Borre","year":"2014","journal-title":"Trends Mol Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40168-017-0242-1","article-title":"New evidences on the altered gut microbiota in autism spectrum disorders","volume":"5","author":"Strati","year":"2017","journal-title":"Microbiome"},{"key":"B36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.physbeh.2014.10.033","article-title":"Gastrointestinal microbiota in children with autism in Slovakia","volume":"138","author":"Tomova","year":"2015","journal-title":"Physiol Behav"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e24585","DOI":"10.1371\/journal.pone.0024585","article-title":"Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances","volume":"6","author":"Williams","year":"2011","journal-title":"PloS ONE"},{"key":"B38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbi.2013.12.005","article-title":"Altered gut microbiota and activity in a murine model of autism spectrum disorders","volume":"37","author":"de Theije","year":"2014","journal-title":"Brain Behav Immun"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e68322","DOI":"10.1371\/journal.pone.0068322","article-title":"Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children","volume":"8","author":"Kang","year":"2013","journal-title":"PloS ONE"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1007\/s00248-018-1176-2","article-title":"Gut microbial dysbiosis in indian children with autism spectrum disorders","volume":"76","author":"Pulikkan","year":"2018","journal-title":"Microbial Ecol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.bbi.2018.03.025","article-title":"Differential immune responses and microbiota profiles in children with autism spectrum disorders and co-morbid gastrointestinal symptoms","volume":"70","author":"Rose","year":"2018","journal-title":"Brain Behav Immun"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1080\/19490976.2020.1747329","article-title":"Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder","volume":"11","author":"Dan","year":"2020","journal-title":"Gut Microbes"},{"key":"B43","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.euroneuro.2014.02.004","article-title":"Blood serotonin levels in autism spectrum disorder: a systematic review and meta-analysis","volume":"24","author":"Gabriele","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1002\/aur.1791","article-title":"Is there sexual dimorphism of hyperserotonemia in autism spectrum disorder?","volume":"10","author":"Shuffrey","year":"2017","journal-title":"Autism Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jcmgh.2019.01.004","article-title":"Modulation of gut microbiota composition by serotonin signaling influences intestinal immune response and susceptibility to colitis","volume":"7","author":"Kwon","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.3389\/fmicb.2019.03067","article-title":"Gut microbiota are associated with psychological stress-induced defections in intestinal and blood-brain barriers","volume":"10","author":"Geng","year":"2019","journal-title":"Front Microbiol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jtemb.2015.12.002","article-title":"Iodine in autism spectrum disorders","volume":"34","author":"Blazewicz","year":"2016","journal-title":"J Trace Elem Med Biol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12974-017-0888-4","article-title":"Serum thyroid-stimulating hormone and interleukin-8 levels in boys with autism spectrum disorder","volume":"14","author":"Singh","year":"2017","journal-title":"J Neuroinflammation"},{"key":"B49","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41564-018-0307-3","article-title":"GABA-modulating bacteria of the human gut microbiota","volume":"4","author":"Strandwitz","year":"2019","journal-title":"Nat Microbiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"eaar2016","DOI":"10.1126\/science.aar2016","article-title":"Microbiota and the social brain","volume":"366","author":"Sherwin","year":"2019","journal-title":"Science (New York, NY)"},{"key":"B51","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy","volume":"16","author":"L\u00f6scher","year":"2002","journal-title":"CNS Drugs"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00343800","article-title":"Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders","volume":"229","author":"Emrich","year":"1980","journal-title":"Arch Psychiatr Nervenkr"},{"key":"B53","doi-asserted-by":"publisher","first-page":"564","DOI":"10.15585\/mmwr.ss6706a1","article-title":"Prevalence of autism spectrum disorder among children aged 8 years -autism and developmental disabilities monitoring network, 11 sites, United States, 2014","volume":"67","author":"Baio","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1056\/NEJMoa0907328","article-title":"Valproic acid monotherapy in pregnancy and major congenital malformations","volume":"362","author":"Jentink","year":"2010","journal-title":"N Engl J Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.annepidem.2011.08.002","article-title":"Use of antiepileptic medications in pregnancy in relation to risks of birth defects","volume":"21","author":"Werler","year":"2011","journal-title":"Ann Epidemiol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.cell.2012.01.035","article-title":"The impact of the gut microbiota on human health: an integrative view","volume":"148","author":"Clemente Jose","year":"2012","journal-title":"Cell"},{"key":"B57","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/526312a","article-title":"The tantalizing links between gut microbes and the brain. Neuroscientists are probing the idea that intestinal microbiota might influence brain development and behaviour","volume":"526","author":"Smith","year":"2015","journal-title":"Nature"},{"key":"B58","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41564-018-0337-x","article-title":"The neuroactive potential of the human gut microbiota in quality of life and depression","volume":"4","author":"Valles-Colomer","year":"2019","journal-title":"Nat Microbiol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s40168-019-0733-3","article-title":"Gut microbiota from NLRP3-deficient mice ameliorates depressive-like behaviors by regulating astrocyte dysfunction via circHIPK2","volume":"7","author":"Zhang","year":"2019","journal-title":"Microbiome"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1136\/gutjnl-2017-314759","article-title":"Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression","volume":"67","author":"Stevens","year":"2018","journal-title":"Gut"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.cell.2018.04.027","article-title":"The gut microbiota mediates the anti-seizure effects of the ketogenic diet","volume":"173","author":"Olson","year":"2018","journal-title":"Cell"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.549810\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T05:15:33Z","timestamp":1615526133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.549810\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":61,"alternative-id":["10.3389\/fpsyt.2021.549810"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2021.549810","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,12]]},"article-number":"549810"}}